| |
siRNA Id: | aspsirna1698
|
siRNA Name: | siCD46-1A5G
|
Gene: | Complement regulatory protein (CD46) |
Disease: | Hemolytic uremic syndrome |
Wild allele/target (5'->3'): | CUUAUUGGAGAGAGCACGA
|
Mutant allele/target (5'->3'): | CUUAUUGGAGAGAGCACGU
|
Target Mutation: | NM_002389.4:c.104G>A, p.Cys35Tyr
|
Wild siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCA
|
Mismatch position in siRNA: | 1A,5G |
Mutant allele (5'->3'): | CUUAUUGGAGAGAGCACGU
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCA
|
ASP-siRNA efficacy for mutant allele: | 98
|
Wild allele (5'->3'): | CUUAUUGGAGAGAGCACGA
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCA
|
ASP-siRNA efficacy for wild allele: | 38
|
Percentage discrimination for ASP-siRNA: | 60
|
Wild allele (5'->3'): | CUUAUUGGAGAGAGCACGA
|
Wild siRNA (As strand): | GAAUAACCUCUCUCGUGCU
|
Wild sirna efficacy for wild allele: | NA
|
Wild allele (5'->3'): | CUUAUUGGAGAGAGCACGA
|
ASP-siRNA (As strand): | GAAUAACCUCUCUCGUGCA
|
Wild sirna efficacy for mutant allele: | 38
|
Percentage discrimination for wild siRNA: | NA
|
Concentration: | 13nM |
Orientation: | Sense |
Mismatch in: | Target gene |
UniProt ID: | P15529 |
Target sequence: | CTTATTGGAGAGAGCACGATTTATTGTGGTGACA |
Genbank Accesion: | NM_002389.4 |
Cell-line: | HEK293 |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Invitrogen |
Post-transfection duration: | 24 hours |
OMID ID: | 120920 |
KEGG disease ID: | H00106, H0027 |
Reference: | 18420656 |